Loading company
Progyny, Inc.
PGNY · Nasdaq · ·
Next earnings: November 5, 2026
$24.80-2.9%Sep 29 close
- 1M
- -4.6%
- 6M
- +46.1%
- 1Y
- +15.2%
- 5Y
- -59.3%
Progyny, Inc. is the 10th largest of 11 graded companies. Showing 5 of them, including PGNY itself.
| Company | Grade | Market value | Revenue | Profit margin | Free cash flow | Price to earnings |
|---|---|---|---|---|---|---|
| UnitedHealth Group IncorporatedUNH | B | $336.6B | $450.1B | 3.1% | $23.6B | 24.11 |
| CVS Health CorporationCVS | B | $111.4B | $415.1B | 1.2% | $11.8B | 22.92 |
| Elevance Health, Inc.ELV | B | $85.2B | $201.1B | 2.5% | $6.3B | 17.40 |
| The Cigna GroupCI | B | $72.7B | $282.4B | 2.3% | — | 11.38 |
| Progyny, Inc.PGNY | B | $1.9B | $1.3B | 6.0% | $178.4M | 26.96 |
A blank price-to-earnings means a loss, not a missing figure — the ratio has no meaning when there are no earnings to divide by, and printing a negative one would make the least profitable company look the cheapest.
Grades are trailing twelve months from each company’s own SEC filings, so they move only when a company files. Every column is computed by the same code that graded Progyny, Inc. on the overview — nothing here comes from a data vendor’s own ratios.
Industry membership is not a judgement about how similar two businesses are. It groups companies by what they are classified as, which is a starting point for comparison rather than a claim that they compete.
6 more healthcare plans companies
Graded on the same five checks, from their own SEC filings.
PGNY · Nasdaq · ·
Next earnings: November 5, 2026
$24.80-2.9%Sep 29 close